+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ex Vivo Skin Explants Market - Global Forecast 2025-2030- Product Image
Ex Vivo Skin Explants Market - Global Forecast 2025-2030- Product Image
Sale

Ex Vivo Skin Explants Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6127238
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Ex vivo skin explants are rapidly redefining biomedical research, establishing a critical niche as high-fidelity models that effectively bridge the gap between traditional in vitro assays and complex in vivo studies. This market report delivers a strategic analysis designed for senior decision-makers seeking to capitalize on leading innovation, evolving regulatory pressures, and shifting global supply chains within the ex vivo skin explant segment.

Market Snapshot: Ex Vivo Skin Explant Market Growth Drivers

The ex vivo skin explant market is shaped by a convergence of technological advancement, increasing regulatory momentum toward non-animal testing, and extended supply chain networks across key geographies. Rising demand for physiologically relevant tissue models in sectors such as pharmaceuticals, cosmetics, and biotechnology is positioning explants as an indispensable resource. As academic and contract research institutions intensify integration of three-dimensional bioprinting and microfluidic technologies, the market’s pace of innovation continues to accelerate. Regional adoption is reinforced by supportive policy frameworks in North America and Europe, with Asia-Pacific rapidly expanding as new research hubs emerge.

Scope & Segmentation: Unpacking the Ex Vivo Skin Explant Landscape

  • Application Areas: Disease modeling—including diabetic and wound healing models—efficacy evaluation for drug screening and formulation testing, basic and translational research, as well as toxicity testing.
  • Product Types: Full thickness and split thickness explants facilitating comprehensive or cost-sensitive studies.
  • Source Options: Human-derived samples prioritized for clinical relevance and porcine tissue valued for scalability and ethical accessibility.
  • End Users: Academic and research institutions, cosmetics developers, contract research organizations, and pharmaceutical and biotech firms.
  • Preservation Techniques: Cryopreserved samples supporting global reach and fresh explants optimized for maximal cell viability.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, major Gulf states, and select African nations), and Asia-Pacific (notably China, India, Japan, Australia, and Southeast Asia).
  • Leading Technologies: Three-dimensional bioprinting and integrated microfluidic systems, enabling dynamic perfusion and advanced tissue modeling.

Key Takeaways for Decision-Makers

  • Ex vivo skin explants deliver robust, real-world modeling by maintaining native tissue architecture, supporting advanced disease and drug interaction studies.
  • Integration of bioprinting and microfluidic technologies is enabling higher-throughput assays, while improving data granularity and translational relevance for industry sponsors.
  • Non-animal test mandates and evolving regulatory landscapes are spurring rapid protocol adoption, influencing market segmentation and fueling investment in standardized preservation and handling methods.
  • Supply chains are adapting through regional diversification, especially as fresh and cryopreserved tissue logistics grow in complexity globally.
  • Strategic partnerships and consortia are crucial for protocol standardization, resource pooling, and maintaining competitive positioning in a sector characterized by accelerating technical evolution.

Tariff Impact: Navigating 2025 Uncertainties in Supply and Costs

Forthcoming United States tariffs targeting biomedical imports in 2025 introduce operational challenges for supply chain continuity and research budgeting in the ex vivo skin explant segment. Cost escalation may prompt institutions to reassess supplier contracts and explore domestic sourcing or novel preservation approaches. Extended procurement lead times are also anticipated as economic incentives shift, emphasizing the need for risk mitigation tactics such as shared logistics and regional tissue bank integration.

Methodology & Data Sources

This analysis synthesizes data from primary interviews with pharmaceutical leaders, academic researchers, and tissue providers, complemented by systematic secondary review of peer-reviewed literature, regulatory guidance, and technical trade documentation. Results are validated through quantitative modeling, qualitative assessment, and expert panel review to ensure accuracy and actionable insight.

Why This Report Matters

  • Enables leaders to align strategic investments with emerging application and technology trends in ex vivo skin explants.
  • Supports proactive risk management and scenario planning around regulatory policy changes and global supply chain fragility.
  • Delivers segmented insights to guide partnership, procurement, and operational decisions across diverse end user profiles and regions.

Conclusion

As regulatory, scientific, and logistical factors reshape the ex vivo skin explant market, success depends on strategic foresight and collaborative engagement. Leveraging the actionable insights and validated methodology in this report positions organizations to drive innovation, standardization, and sustainable growth across biomedical research and product development ecosystems.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of three-dimensional bioprinting techniques to produce customizable ex vivo skin explant models for advanced therapeutic testing
5.2. Regulatory framework harmonization across regions facilitating the replacement of animal testing with ex vivo human skin explant assays
5.3. Development of novel perfusion bioreactor systems to extend viability and functionality of ex vivo skin explants in long-term research studies
5.4. Increasing integration of multi-omics and high-content imaging analytics in ex vivo skin explant research for precision dermatology insights
5.5. Surging demand for personalized dermatological safety testing using patient-derived ex vivo skin explants in drug development pipelines
5.6. Strategic collaborations between pharmaceutical companies and CROs to expand ex vivo skin explant service offerings and accelerate go-to-market timelines
5.7. Expansion of ethically sourced human donor tissue biobanks to supply standardized ex vivo skin explants for pharmaceutical and cosmetic research
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Ex Vivo Skin Explants Market, by Application
8.1. Introduction
8.2. Disease Modeling
8.2.1. Diabetic Model
8.2.2. Wound Healing Model
8.3. Efficacy Evaluation
8.3.1. Drug Screening
8.3.2. Formulation Testing
8.4. Research & Development
8.4.1. Basic Research
8.4.2. Translational Research
8.5. Toxicity Testing
9. Ex Vivo Skin Explants Market, by Product Type
9.1. Introduction
9.2. Full Thickness
9.3. Split Thickness
10. Ex Vivo Skin Explants Market, by Source
10.1. Introduction
10.2. Human
10.3. Porcine
11. Ex Vivo Skin Explants Market, by End User
11.1. Introduction
11.2. Academic & Research
11.3. Cosmetics
11.4. CROs
11.5. Pharmaceutical & Biotech
12. Ex Vivo Skin Explants Market, by Preservation Technique
12.1. Introduction
12.2. Cryopreserved
12.3. Fresh
13. Americas Ex Vivo Skin Explants Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Ex Vivo Skin Explants Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Ex Vivo Skin Explants Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. MatTek Corporation
16.3.2. L'Oréal S.A.
16.3.3. Givaudan S.A.
16.3.4. Henkel AG & Co. KGaA
16.3.5. CellSystems GmbH
16.3.6. Genoskin S.A.
16.3.7. XCell Science Inc.
16.3.8. BioIVT, LLC
16.3.9. Scantox a/S
16.3.10. Tissue Solutions Ltd
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. EX VIVO SKIN EXPLANTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC EX VIVO SKIN EXPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC EX VIVO SKIN EXPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EX VIVO SKIN EXPLANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. EX VIVO SKIN EXPLANTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. EX VIVO SKIN EXPLANTS MARKET: RESEARCHAI
FIGURE 26. EX VIVO SKIN EXPLANTS MARKET: RESEARCHSTATISTICS
FIGURE 27. EX VIVO SKIN EXPLANTS MARKET: RESEARCHCONTACTS
FIGURE 28. EX VIVO SKIN EXPLANTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. EX VIVO SKIN EXPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY DIABETIC MODEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY DIABETIC MODEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY WOUND HEALING MODEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY WOUND HEALING MODEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY DRUG SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY DRUG SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY FORMULATION TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY FORMULATION TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY FULL THICKNESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY FULL THICKNESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY SPLIT THICKNESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY SPLIT THICKNESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY HUMAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY HUMAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PORCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY ACADEMIC & RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY ACADEMIC & RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY COSMETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY COSMETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY CRYOPRESERVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY CRYOPRESERVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY FRESH, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL EX VIVO SKIN EXPLANTS MARKET SIZE, BY FRESH, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS EX VIVO SKIN EXPLANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 104. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 105. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 108. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 109. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 112. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 113. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 116. CANADA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 120. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 121. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 124. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 125. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 199. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 202. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 203. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 204. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 205. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 206. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 207. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 210. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 211. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 214. GERMANY EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 215. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 218. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 219. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 220. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 222. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 223. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 226. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 227. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 230. FRANCE EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 247. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 250. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 251. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 252. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 253. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 254. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 255. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 258. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 259. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 262. ITALY EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 263. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 266. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 267. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 268. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 269. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 270. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 271. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 274. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 275. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 278. SPAIN EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY EFFICACY EVALUATION, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA EX VIVO SKIN EXPLANTS MARKET SIZE, BY PRESERVATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 327. DENMARK EX VIVO SKIN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Ex Vivo Skin Explants market report include:
  • MatTek Corporation
  • L'Oréal S.A.
  • Givaudan S.A.
  • Henkel AG & Co. KGaA
  • CellSystems GmbH
  • Genoskin S.A.
  • XCell Science Inc.
  • BioIVT, LLC
  • Scantox A/S
  • Tissue Solutions Ltd

Related Reports

Cosmetics Testing & Analysis Services Market - Global Forecast 2025-2030 - Product Image

Cosmetics Testing & Analysis Services Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Primary Cell Culture Market Report 2025 - Product Image

Primary Cell Culture Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Plant Tissue Culture - Global Strategic Business Report - Product Image

Plant Tissue Culture - Global Strategic Business Report

  • Report
  • 389 Pages
  • Global
From
Transdermal Diffusion Sampling System Market - Global Forecast 2025-2030 - Product Image

Transdermal Diffusion Sampling System Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Perfusion Systems - Global Strategic Business Report - Product Image

Perfusion Systems - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.